Since sovaSage Incorporated, a Pittsburgh based company, first announced its new zero contact patient management software, TherapistAssist™, in October of this year, this revolutionary means of managing CPAP patients using its patent-pending telemedicine technology is taking hold.
“The industry’s response to our product has been like nothing that I have ever experienced.”, remarked William Kaigler, co-founder, and CEO of sovaSage.
Rarely does the perfect solution become available at the perfect time. That appears to be the case with this new product, designed to assist respiratory therapists in managing CPAP, BiPAP, and Auto-PAP therapies by leveraging artificial intelligence, novel computer vision technologies.
The zero-touch COVID-19 compliant product delivers significant clinical and financial benefits to the patient and the provider, including the ability to significantly increase the number of patients a clinician can see in a day while simultaneously reducing mask exchanges due to improper or sub-optimal selection or sizing of masks.
The company reports extremely high interest in their product and is staffing up to handle increased demand due to better than expected customer adoption and sales.
To learn more about the sovaSage TherapistAssist software product, please visit our website today at www.sovasage.com and request a demo.